BenevolentAI
London-based AI-drug-discovery company using a biomedical knowledge graph to identify novel disease mechanisms and therapeutic targets.
Profile
BenevolentAI is one of the highest-profile UK AI-biotech crossovers, with multiple pharma partnerships (AstraZeneca, Merck) and a public Euronext Amsterdam listing.
British link
Headquartered in London.
Sectorai
Stagepublic
FundingPublic (Euronext)
Employees300+
Founded2013